COLUMBIA, S.C., Oct. 24 (UPI) -- Eli Lilly has agreed to pay South Carolina a record $45 million to settle a dispute over the marketing of the anti-psychotic drug Zyprexa, officials say.
FARGO, N.D., March 27 (UPI) -- U.S. doctors have tested a treatment for weight gain caused by some anti-psychotic medications.
WASHINGTON, July 1 (UPI) -- The U.S. Food and Drug Administration says it's approved the first generic versions of Risperdal tablets for certain psychiatric disorders.
UTRECHT, Netherlands, April 18 (UPI) -- Elderly patients taking anti-psychotic drugs have a 60 percent increased risk of pneumonia, a Dutch study finds.
CHAPEL HILL, N.C., March 8 (UPI) -- Schizophrenics not responding to the older antipsychotic drug perphenazine did better on a newer drug, quetiapine, say U.S. scientists.
NEW YORK, June 6 (UPI) -- New U.S. research shows the use of prescription anti-psychotic drugs to treat children and teenagers rose fivefold between 1993 and 2002.
CHICAGO, Feb. 8 (UPI) -- Researchers in Chicago have found a schizophrenia drug blocks the addictive effects of painkillers in mice.
NEW YORK, Sept. 20 (UPI) -- The most comprehensive comparative U.S. study ever concludes that new anti-psychotic drugs are no more effective than an older medication and cost far more.
INDIANAPOLIS, June 10 (UPI) -- Eli Lilly & Co. of Indianapolis plans to pay up to $690 million to settle as many as 8,000 claims against its anti-psychotic drug Zyprexa.
NEW YORK, Aug. 22 (UPI) -- A new class of anti-psychotic drugs has been linked to increased rates of diabetes, according to a new study.
